SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56199
 
  
 
C07K PEPTIDES 25111
 
  
 
C07D HETEROCYCLIC COMPOUNDS 22140
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 14153
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11195
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 8130
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 643
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0334,889 COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSEAug 09, 17Nov 23, 17[A61K, C07D, C07C]
2017/0326,245 Methods and Compositions Related To Annexin 1-Binding CompoundsApr 04, 17Nov 16, 17[A61K]
2017/0198,047 PSGL-1 MODULATORS AND USES THEREOFJul 08, 15Jul 13, 17[C07K]
2017/0182,095 METHODS AND COMPOSITIONS TO MODULATE HAIR GROWTHJul 07, 15Jun 29, 17[A61K, C12N]
2017/0166,972 LONG NON-CODING RNA AS A DIAGNOSTIC AND THERAPEUTIC AGENTNov 26, 14Jun 15, 17[C12Q, C12N]
2016/0346,311 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTMar 31, 16Dec 01, 16[A61K, C12Q, C12N]
2016/0340,324 METHODS AND COMPOSITIONS FOR TREATING CANCERDec 22, 14Nov 24, 16[G06N, A61K, C07D, G06F]
2016/0194,403 MODULATION OF GAMMA DELTA T CELLSSep 04, 14Jul 07, 16[C12N, G01N, C07K]
2015/0329,497 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1Dec 19, 13Nov 19, 15[A61K, C07D]
2014/0024,597 INTRANASAL DELIVERY OF CELL PERMEANT THERAPEUTICSFeb 15, 13Jan 23, 14[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9884826 Sulfonamide compounds and uses as TNAP inhibitorsAug 19, 16Feb 06, 18[A61K, C07D, A61P]
9878050 Delivery of agents using interfering nanoparticlesDec 09, 16Jan 30, 18[A61K, C12N]
9868707 Small molecule agonists of neurotensin receptor 1Dec 19, 13Jan 16, 18[A61K, C07D]
9783576 Compositions and methods for targeted endometriosis treatmentJun 11, 14Oct 10, 17[A61K, C07K]
9776979 EBI2 modulatorsSep 26, 14Oct 03, 17[C07F, C07D]
9732067 Compounds and methods for activating the apoptotic arm of the unfolded protein responseJun 18, 13Aug 15, 17[A61K, C07D, C07C]
9610359 Methods and compositions related to annexin 1-binding compoundsDec 23, 10Apr 04, 17[A61K, A61P, C07K]
9611235 Methods and compositions related to a retinoid receptor-selective pathwayMay 06, 11Apr 04, 17[A61K, C07D, C07C, G01N]
9598402 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infectionsAug 10, 12Mar 21, 17[A61K, C07D]
9581598 Diagnosis and treatment of brain tumorApr 25, 13Feb 28, 17[A61K, C12N, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0232,293 DRUG SENSITIVITY BIOMARKERS AND METHODS OF IDENTIFYING AND USING DRUG SENSITIVITY BIOMARKERSAbandonedOct 17, 14Aug 11, 16[G01N, G06F]
2016/0022,831 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsAbandonedMar 22, 15Jan 28, 16[A61K, C07K]
2015/0266,964 METHODS FOR ACCELERATING IMMUNE REGENERATIONAbandonedOct 04, 13Sep 24, 15[C07K]
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESAbandonedMar 14, 13Feb 19, 15[C07K]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYAbandonedDec 17, 13Aug 28, 14[C12N, G01N]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAAbandonedMar 15, 13May 15, 14[A61K, C12Q, C12N]
2014/0005,181 SMALL MOLECULE ANTAGONISTS OF THE APELIN RECEPTOR FOR THE TREATMENT OF DISEASEAbandonedJun 20, 13Jan 02, 14[C07D]
8598316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignanciesExpiredMar 26, 10Dec 03, 13[A61K]
8536132 Lymphatic zip codes in tumors and pre-malignant lesionsExpiredFeb 10, 11Sep 17, 13[A61K, A61P]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEAbandonedSep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSAbandonedNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONAbandonedFeb 08, 13Aug 15, 13[G06F]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEAbandonedDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISAbandonedDec 02, 10Jun 20, 13[G01N]
2013/0136,786 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTAbandonedFeb 09, 12May 30, 13[C12Q, C12N]
2013/0084,328 METHYLATED CODING AND NON-CODING RNA GENES AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR HUMAN MELANOMAAbandonedApr 26, 12Apr 04, 13[C12Q]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGAbandonedMay 31, 12Mar 14, 13[A61K, C12N, G01N, C40B]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESAbandonedFeb 28, 12Mar 07, 13[A61K, B82Y, A61P, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSAbandonedOct 31, 11Nov 01, 12[A61K, C12Q, G01N, A61P, C40B, C07K]
2012/0269,901 Methods and Compounds Useful to Induce Apoptosis in Cancer CellsAbandonedDec 19, 11Oct 25, 12[A61K, G01N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.